Icatibant 63323-0574
Product NDC
63323-0574- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 15, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA208317
Need to source Icatibant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Icatibant Acetate | 10 mg/mL |
Drug Class
Bradykinin B2 Receptor Antagonist [EPC]Bradykinin B2 Receptor Antagonists [MoA]
Packaging Options(2)
1 SYRINGE in 1 CARTON (63323-574-86) / 3 mL in 1 SYRINGE (63323-574-01)
3 CARTON in 1 BOX (63323-574-93) / 1 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE